1. Home
  2. INKT vs FEMY Comparison

INKT vs FEMY Comparison

Compare INKT & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INKT
  • FEMY
  • Stock Information
  • Founded
  • INKT 2017
  • FEMY 2004
  • Country
  • INKT United States
  • FEMY United States
  • Employees
  • INKT N/A
  • FEMY N/A
  • Industry
  • INKT Medicinal Chemicals and Botanical Products
  • FEMY Medical/Dental Instruments
  • Sector
  • INKT Health Care
  • FEMY Health Care
  • Exchange
  • INKT Nasdaq
  • FEMY Nasdaq
  • Market Cap
  • INKT 28.8M
  • FEMY 31.9M
  • IPO Year
  • INKT 2021
  • FEMY 2021
  • Fundamental
  • Price
  • INKT $28.65
  • FEMY $0.94
  • Analyst Decision
  • INKT Buy
  • FEMY Strong Buy
  • Analyst Count
  • INKT 3
  • FEMY 3
  • Target Price
  • INKT $37.50
  • FEMY $8.67
  • AVG Volume (30 Days)
  • INKT 2.6M
  • FEMY 262.9K
  • Earning Date
  • INKT 08-12-2025
  • FEMY 08-07-2025
  • Dividend Yield
  • INKT N/A
  • FEMY N/A
  • EPS Growth
  • INKT N/A
  • FEMY N/A
  • EPS
  • INKT N/A
  • FEMY N/A
  • Revenue
  • INKT N/A
  • FEMY $1,699,232.00
  • Revenue This Year
  • INKT N/A
  • FEMY $231.84
  • Revenue Next Year
  • INKT N/A
  • FEMY $245.28
  • P/E Ratio
  • INKT N/A
  • FEMY N/A
  • Revenue Growth
  • INKT N/A
  • FEMY 61.97
  • 52 Week Low
  • INKT $4.56
  • FEMY $0.69
  • 52 Week High
  • INKT $76.00
  • FEMY $1.80
  • Technical
  • Relative Strength Index (RSI)
  • INKT 60.80
  • FEMY 46.49
  • Support Level
  • INKT $6.80
  • FEMY $0.90
  • Resistance Level
  • INKT $76.00
  • FEMY $0.99
  • Average True Range (ATR)
  • INKT 5.95
  • FEMY 0.06
  • MACD
  • INKT 3.73
  • FEMY 0.00
  • Stochastic Oscillator
  • INKT 35.31
  • FEMY 16.86

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: